This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Stelling Classification

Authoring team

The Stelling Classification describes the general features of polydactyly in relation to an extra digit. It was originally described in relation to ulnar (post-axial) polydactyly:

  • type I: there is an extra soft tissue mass or digit that is attached by a soft tissue bridge
  • type II: an extra digit (partial or complete) that articulates with a normal metacarpal or phalanx
  • type III: an extra digit articulating with an extra metacarpal

Type I is the most common. The most frequent site for type I is on the ulnar border of the little finger at the level of the proximal phalanx.

The Stelling Classification is useful in that it provides a broad framework for treatment:

  • type I:
    • traditionally ligated with a suture, now best treated surgically
    • a ligaclip can be applied to the stalk, but this may result in a residual nubbins after healing and a potentially tender neuroma from the nerve within the stalk
    • best treated with formal excision and burying of the neurovascular pedicle to prevent neuroma; may be safely done in a young, starved child without the need for general anaesthesia by administration of a distracting feed
  • type II:
    • complete excision of digit using flap of skin from removed part to close base of digit
  • type III:
    • excision of phalanges and metacarpal
    • redraping of soft tissue envelope
    • recreation of intermetacarpal ligament for central anomalies

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.